title: Special considerations for medication use in children with developmental disabilities.
abstract: Regardless of the underlying cause of a child's developmental disability, a similar constellation of associated medical conditions may occur. Successful management approaches in children with developmental disabilities are generally interdisciplinary, frequently involving a variety of medical and surgical disciplines, allied health professionals, and the child's family. Pharmacologic intervention is an integral aspect of the management plan, but consideration must be given both to the possible effects of the medications on a child's growth and development, and to the avoidance of adverse drug interactions and reactions.
authors.affiliation: Department of Pediatrics and Child Health, University of Manitoba, Winnipeg Children's Hospital, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Rempel
authors.forename: J
authors.initials: J
authors.lastname: Coates
mesh_terms: D000293:Adolescent; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002491:Central Nervous System Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002658:Developmental Disabilities / Q000188:drug therapy* / Q000534:rehabilitation; D004305:Dose-Response Relationship, Drug; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000627:therapeutic use*; D018570:Risk Assessment; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D002491:Central Nervous System Agents; D005765:Gastrointestinal Agents; D009125:Muscle Relaxants, Central; D014149:Tranquilizing Agents